Retinol binding protein-4 elevation is associated with serum thyroid-stimulating hormone
level independently of obesity in elderly subjects with normal glucose tolerance.
Falsely elevated thyroid-stimulating hormone
(TSH) level due to macro-TSH.
Table 1: Comparison of T3, T4, and TSH level (mean [+ or -] SD) in study subjects (males and females) Gender Hormone level T3 (nmol/L) T4(nmol/L) TSH (mIU/L) Male 1.99 [+ or -] 0.6 87.99 [+ or -] 16.7 2.66 [+ or -] 2.3 Female 1.44 [+ or -] 0.8 86.6 [+ or -] 34.8 3.88 [+ or -] 1.5 SD: Standard deviation, TSH: Thyroid-stimulating hormone
Table 2: Mean [+ or -] SD of age, TSH, and prolactin of study subjects (patients having hypothyroidism) Parameters Patients Age (years) 34.15 [+ or -] 6.18 TSH (mIU/L) 8.31 [+ or -] 2.5 Prolactin (ng/ml) 37.96 [+ or -] 3.88 SD: Standard deviation, TSH: Thyroid-stimulating hormone
For women with unexplained infertility, thyroid-stimulating hormone
(TSH) averaged 1.95 mIU/ mL (95% confidence interval, 1.54-2.61), compared with 1.66 mIU /mL for the group of women with severe male factor infertility, such as severe oligospermia or azoospermia (95% CI, 1.25-2.17; P = .003).
Relationship between Body Mass Index, Waist-to-Hip Ratio, and Serum Lipid Concentrations and Thyroid-Stimulating Hormone
in the Euthyroid Adult Population.
stimulates increases in inositol phosphates as well as cyclic AMP in the FRTL-5 rat thyroid cell line.
The levels of serum LH, FSH, progesterone (P), estradiol (E2), prolactin (PRL), thyroid-stimulating hormone
, testosterone (T) and sex hormone-binding globulin were measured to assess hormonal status.
The study included 218 Hashimoto's thyroiditis patients with normal thyroid-stimulating hormone
GD is an autoimmune disorder in which the immune system produces autoantibodies called thyroid-stimulating immunoglobulin (TSI) that bind to thyroid-stimulating hormone
(TSH) receptor sites on the thyroid follicular cells.
Demographic data included age, sex, laryngopharyngeal reflux disease, allergy, smoking, duration of disease, presence or absence of compressive symptoms, presence or absence of thyroid gland nodules, vascular status, presence or absence of calcifications, and thyroid-stimulating hormone
Neonatal thyroid-stimulating hormone
screening as a monitoring tool for iodine deficiency in Turkey.
Graves' hyperthyroidism occurs after the loss of tolerance to the thyroid stimulating hormone receptor (TSHR) and the generation of thyroid stimulatory antibodies that mimic the action of thyroid-stimulating hormone